Neuroleptic Malignant Syndrome (NMS) is a serious medical condition that requires emergency intervention and can be life-threatening, although it is rare. It usually occurs following the use of antipsychotic (neuroleptic) drugs and affects the central nervous system, muscular system, and autonomic nervous system.
Because Neuroleptic Malignant Syndrome develops particularly due to medications used in psychiatric treatments, it is a syndrome of vital importance to know for both patients and their relatives. It is considered an emergency because it can lead to fatal outcomes if not recognized early.
The clinical significance of Neuroleptic Malignant Syndrome stems not only from its rarity, but also from its ability to progress rapidly and insidiously and affect multiple organ systems simultaneously. During the course of the disease, the body's heat regulation mechanism is disrupted, and uncontrolled, high fever may develop; the accompanying severe muscle rigidity can lead to widespread damage to muscle tissue and rhabdomyolysis. This condition poses a serious threat to many organs, especially the kidneys. At the same time, conditions that directly affect vital functions, such as cardiac arrhythmias, blood pressure fluctuations, and respiratory failure, may arise.
Therefore, Neuroleptic Malignant Syndrome should be evaluated not merely as a drug side effect during psychiatric treatment, but as a medical emergency. A high level of awareness regarding this syndrome among both physicians and patients is of great importance in preventing early signs from being overlooked. Prompt medical evaluation without delay when fever, muscle stiffness, altered consciousness, or autonomic symptoms develop is the most critical factor determining the course of the disease. With timely diagnosis, rapid discontinuation of the offending drug, and the initiation of appropriate supportive care, NMS can be brought under control in most cases; thus, the risk of permanent organ damage and mortality can be significantly reduced.
What Causes Neuroleptic Malignant Syndrome?
The causes of Neuroleptic Malignant Syndrome are largely related to medications that suppress the dopamine system. The sudden and powerful blockade of dopamine receptors in the brain disrupts the body's heat regulation and muscle control mechanisms.
Most common causes:
- Use of antipsychotic medications at high doses
- Rapid dose escalation of the medication
- Concomitant use of multiple antipsychotic drugs
- Abrupt discontinuation of dopamine agonists
- Dehydration
- Infection or severe physical stress
Neuroleptic Malignant Syndrome does not occur in every individual; however, the probability of it occurring is significantly increased in persons with risk factors.
Neuroleptic Malignant Syndrome does not occur in every individual; however, the probability of it occurring is significantly increased in persons with risk factors. Therefore, especially in high-risk patients, antipsychotic treatment should be initiated at a low dose, slow titration should be performed, and patients should be kept under close clinical monitoring. Recognizing early signs and discontinuing the medication in a timely manner significantly improves the course of the disease and the prognosis.
What Are the Symptoms of Neuroleptic Malignant Syndrome?
Symptoms of Neuroleptic Malignant Syndrome (NMS) generally appear within the first 1–2 weeks after starting the antipsychotic medication; however, in some cases, they may also develop months later or following an increase in the dose of a long-used medication. Symptoms are often sudden in onset and can rapidly worsen within hours to days. Findings appearing in the early period are frequently nonspecific and may be confused with infection or other systemic diseases; this situation can lead to a delay in diagnosis.
As the syndrome progresses, involvement of the muscular system, central nervous system, and autonomic nervous system becomes prominent. The general condition of patients deteriorates rapidly, alterations in consciousness may develop, and life-threatening complications can emerge. Therefore, the early recognition of NMS symptoms is of critical importance for rapid intervention.
Most common symptoms:
High Fever
- Above 38.5°C
- Resistant to antipyretics (fever reducers)
Muscle Stiffness (Rigidity)
- Widespread muscle stiffness in a "lead-pipe" fashion
- Restriction of movement
Alterations in Consciousness
- Confusion
- Agitation
- Clouding of consciousness
- Coma
Autonomic Nervous System Findings
- Rapid heartbeat (tachycardia)
- Blood pressure irregularity
- Excessive sweating
- Increased respiratory rate
The co-occurrence of these symptoms is considered a serious warning regarding Neuroleptic Malignant Syndrome.
Diagnostic Criteria for Neuroleptic Malignant Syndrome
The diagnosis of Neuroleptic Malignant Syndrome is not made with a single test. Clinical findings and laboratory results are evaluated together. The diagnosis of Neuroleptic Malignant Syndrome (NMS) cannot be made through a single specific laboratory test or imaging method. The diagnostic process relies heavily on clinical suspicion and requires the joint evaluation of the patient's history of medication use, clinical symptoms, and laboratory findings. NMS must definitely be kept in mind, particularly in patients with a history of antipsychotic drug use who develop high fever, muscle stiffness, and altered consciousness within a short period.
One of the most important points in making a diagnosis is that the disease can be confused in the early stage with conditions such as infection, sepsis, serotonin syndrome, or malignant hyperthermia. Therefore, taking a detailed medical history and inquiring about a recent history of initiating medication, increasing doses, or discontinuing dopaminergic drugs is of great importance. At the same time, because the clinical picture can worsen rapidly, the diagnostic process must not delay treatment; in the presence of strong clinical suspicion, treatment may be initiated even before the diagnosis is confirmed.
Although laboratory examinations are not diagnostic on their own, they are supportive of the clinical evaluation and are valuable in monitoring the severity of the disease, potential complications, and response to treatment. Therefore, the diagnosis of NMS is established through a holistic approach in which clinical findings are at the forefront and laboratory results support the diagnosis.
Basic criteria used in diagnosis:
Major Criteria
- High fever
- Severe muscle stiffness
- History of antipsychotic medication use
Minor Criteria
- Alteration in consciousness
- Tachycardia
- Blood pressure irregularity
- Leukocytosis (increase in white blood cells)
- Elevated creatine kinase (CK)
Similar conditions such as infections, serotonin syndrome, and malignant hyperthermia must definitely be excluded when making a diagnosis.
How is Neuroleptic Malignant Syndrome Treated?
The treatment of Neuroleptic Malignant Syndrome must certainly be carried out in a hospital and preferably under intensive care conditions.
Basic steps of treatment:
1. Immediate Discontinuation of the Causative Drug
2. Intensive Supportive Care
- Fluid therapy
- Fever control
- Electrolyte balance
3. Muscle Relaxants and Dopamine Agonists
- At the physician's discretion based on the clinical condition
4. Prevention of Complications
- Renal failure
- Respiratory failure
- Cardiac arrhythmias